Bioqpharma Consultancy Limited
12901698
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 24/09/2020
DIRECTOR
BRITISH · ENGLAND · Age 58
Also on 2 other boards
director · Since 24/09/2020
DIRECTOR
BRITISH · ENGLAND · Age 61
Also on 2 other boards
Persons with Significant Control
Dr. Jasvinder Kaur Uppal
British · England · Age 58
34, Rose Street, Wokingham, RG40 1XU
Notified 24/09/2020
CompanyRankvs 1538+ SIC 63990 peers77
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/07/2025
Net Worth
£1.4M
Balance sheet strength
Cash
£2.2M
Cash in the bank
Net Current Assets
£2.0M
Working capital
Current Assets
£2.2M
Current Liabilities
£194k
Fixed Assets
£10k
Debtors
£11k
Tax at Year End
Director Loans
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit | Est. Revenue |
|---|---|---|---|
| 2025 | 11.24 | +£89k | — |
| 2024 | 2.04 | +£394k | £219k |
| 2023 | 1.56 | +£426k | £219k |
| 2022 | 1.30 | +£426k | — |
| 2021 | 0.94 | — | — |
Derived from filed accounts. Not audited figures.